Medica 2025
Reagena is attending Medica 2025. From 17 to 20 November 2025, MEDICA will once again gather...
Read more Medica 2025News
Mika Laava to strengthen new mobile product group
Mika Laava, a graduate engineer, has joined Reagena's Product Development and Quality organization...
Read more Mika Laava to strengthen new mobile product group
2025 Annual Congress of the SSM
We are attending Annual congress of the Swiss Society for Microbiology (SSM) at Interlaken 27-28...
Read more 2025 Annual Congress of the SSM
Meet us at ESCMID 2025 at Vienna
Reagena is participating in ESCMID (Congress of the European Society of Clinical Microbiology and...
Read more Meet us at ESCMID 2025 at Vienna
Kinetics of tick-borne encephalitis virus IgM antibody responses in serum and cerebrospinal fluid
We are excited to share that a recent publication has highlighted our ReaScan TBE IgM rapid...
Read more Kinetics of tick-borne encephalitis virus IgM antibody responses in serum and cerebrospinal fluid
TICK SEASON 2024 CAMPAIGN – WE HAVE A WINNER…
Reagena announced a sales campaign of Reagena’s products for tick-transmitted...
Read more TICK SEASON 2024 CAMPAIGN – WE HAVE A WINNER…
Development of new ReaScan Mobile tests
Duration12/2023 - 12/2025 Total Budget498 520 € EU funding228 960 € Our...
Read more Development of new ReaScan Mobile tests
ESCMID Global 2024
ECCMID is now ESCMID Global 2024. At the end of this month, Barcelona and ESCMID Global 2024 are...
Read more ESCMID Global 2024
ITPD 2023
Reagena is participating in International Symposium on Tick-Borne Pathogens and Disease in Vienna,...
Read more ITPD 2023
10th European Meeting on Viral Zoonoses
Reagena is attending the 10th European Meeting on Viral Zoonoses in St Raphaël, France 23 –...
Read more 10th European Meeting on Viral Zoonoses